Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncollagen binding

VTN FN1 MAP1A ITGA10 ITGA1 AP1G1 P3H1 CTSB

2.54e-07811588GO:0005518
GeneOntologyMolecularFunctionintegrin binding

VTN FN1 L1CAM ITGA10 LAMB1 ITGA1 NISCH UTRN

7.82e-051751588GO:0005178
GeneOntologyMolecularFunctionphosphoglucomutase activity

PGM1 PGM5

1.86e-0431582GO:0004614
GeneOntologyBiologicalProcessneuron development

CACNA1F FAT4 LHX4 FN1 MAP1A MYO5B SZT2 FAT3 L1CAM ETV1 ETV4 LAMB1 ITGA1 LHX6 PRAG1 KIF20B KIAA0319 UNC5A TH ALMS1 IFT88 WASHC5 P3H1 FUT9 DLG4 DENND5A PBX2 PBX3 ZBTB18 CDH11

6.29e-07146315830GO:0048666
GeneOntologyBiologicalProcesscell-substrate adhesion

VTN COL17A1 FN1 L1CAM ITGA10 LAMB1 SORBS1 ITGA1 AKIP1 FAT2 PKD1 SGCE UTRN CDH11

3.44e-0641015814GO:0031589
GeneOntologyBiologicalProcesscell-matrix adhesion

VTN COL17A1 FN1 L1CAM ITGA10 SORBS1 ITGA1 PKD1 SGCE UTRN CDH11

7.77e-0627015811GO:0007160
GeneOntologyBiologicalProcessneuron projection development

CACNA1F FAT4 LHX4 FN1 MAP1A MYO5B SZT2 FAT3 L1CAM ETV1 ETV4 LAMB1 ITGA1 PRAG1 KIF20B KIAA0319 UNC5A ALMS1 IFT88 WASHC5 P3H1 FUT9 DLG4 DENND5A CDH11

1.54e-05128515825GO:0031175
GeneOntologyCellularComponentbasement membrane

VTN COL17A1 FN1 ACTA2 LAMB1 RPSA P3H1

4.33e-051221607GO:0005604
DomainETS_PEA3_N

ETV1 ETV4 ETV5

6.05e-0731593IPR006715
DomainETS_PEA3_N

ETV1 ETV4 ETV5

6.05e-0731593PF04621
DomainPKD/REJ-like

PKD1L1 KIAA0319 PKD1

1.19e-0561593IPR002859
DomainREJ

PKD1L1 KIAA0319 PKD1

1.19e-0561593PF02010
DomainPKD/Chitinase_dom

PKD1L1 KIAA0319 PKD1

4.90e-0591593IPR022409
DomainPKD

PKD1L1 KIAA0319 PKD1

4.90e-0591593SM00089
DomainPKD

PKD1L1 KIAA0319 PKD1

9.50e-05111593PS50093
DomainPKD_dom

PKD1L1 KIAA0319 PKD1

9.50e-05111593IPR000601
Domain-

PKD1L1 KIAA0319 PKD1

9.50e-051115932.60.40.670
DomainPGM_PMM_III

PGM1 PGM5

4.27e-0441592PF02880
DomainA-D-PHexomutase_CS

PGM1 PGM5

4.27e-0441592IPR016066
DomainA-D-PHexomutase_a/b/a-III

PGM1 PGM5

4.27e-0441592IPR005846
DomainREJ

PKD1L1 PKD1

4.27e-0441592PS51111
DomainPBC

PBX2 PBX3

4.27e-0441592PF03792
DomainPBX

PBX2 PBX3

4.27e-0441592IPR005542
DomainREJ_dom

PKD1L1 PKD1

4.27e-0441592IPR014010
DomainConA-like_dom

FAT4 FAT3 CANX CMYA5 TRIM10 FAT2 PAPPA BTNL9

5.86e-042191598IPR013320
DomainPGM_PMM

PGM1 PGM5

7.08e-0451592PS00710
DomainPGM_PMM_II

PGM1 PGM5

7.08e-0451592PF02879
DomainPGM_PMM_I

PGM1 PGM5

7.08e-0451592PF02878
DomainPGM_PMM_IV

PGM1 PGM5

7.08e-0451592PF00408
Domain-

PGM1 PGM5

7.08e-04515923.40.120.10
DomainA-D-PHexomutase_a/b/a-I/II/III

PGM1 PGM5

7.08e-0451592IPR016055
DomainMyosin_S1_N

MYO5A MYO5B

7.08e-0451592IPR008989
DomainA-D-PHexomutase_a/b/a-I

PGM1 PGM5

7.08e-0451592IPR005844
DomainA-D-PHexomutase_a/b/a-II

PGM1 PGM5

7.08e-0451592IPR005845
DomainA-D-PHexomutase_C

PGM1 PGM5

7.08e-0451592IPR005843
DomainAlpha-D-phosphohexomutase_SF

PGM1 PGM5

7.08e-0451592IPR005841
Domain-

PGM1 PGM5

7.08e-04515923.30.310.50
Domain-

PKD1L1 PKD1 DENND5A

7.19e-042115932.60.60.20
DomainPLAT

PKD1L1 PKD1 DENND5A

7.19e-04211593PF01477
DomainPLAT/LH2_dom

PKD1L1 PKD1 DENND5A

7.19e-04211593IPR001024
DomainPLAT

PKD1L1 PKD1 DENND5A

7.19e-04211593PS50095
Domain-

PITPNM2 STARD8 STARD9

9.46e-042315933.30.530.20
DomainSTART-like_dom

PITPNM2 STARD8 STARD9

9.46e-04231593IPR023393
DomainFN3

IL12RB2 LRFN1 FN1 L1CAM FNDC3A CMYA5 KIAA0319

1.05e-031851597SM00060
DomainDilute_dom

MYO5A MYO5B

1.06e-0361592IPR002710
DomainDIL

MYO5A MYO5B

1.06e-0361592PF01843
DomainDILUTE

MYO5A MYO5B

1.06e-0361592PS51126
DomainDIL

MYO5A MYO5B

1.06e-0361592SM01132
Domain-

FAT4 FAT3 CANX FAT2 PAPPA

1.31e-039515952.60.120.200
DomainPKD

PKD1L1 PKD1

1.47e-0371592PF00801
DomainEGF_1

FAT4 FN1 FAT3 NRG2 LAMB1 MATN4 FAT2 LRP5

1.56e-032551598PS00022
DomainETS_DOMAIN_1

ETV1 ETV4 ETV5

1.70e-03281593PS00345
DomainETS_DOMAIN_2

ETV1 ETV4 ETV5

1.70e-03281593PS00346
DomainEts

ETV1 ETV4 ETV5

1.70e-03281593PF00178
DomainETS

ETV1 ETV4 ETV5

1.70e-03281593SM00413
DomainEts_dom

ETV1 ETV4 ETV5

1.70e-03281593IPR000418
DomainETS_DOMAIN_3

ETV1 ETV4 ETV5

1.70e-03281593PS50061
DomainEGF-like_CS

FAT4 FN1 FAT3 NRG2 LAMB1 MATN4 FAT2 LRP5

1.81e-032611598IPR013032
DomainSLC12_C

SLC12A1 SLC12A9

1.95e-0381592IPR018491
DomainSLC12

SLC12A1 SLC12A9

1.95e-0381592PF03522
DomainFN3_dom

IL12RB2 LRFN1 FN1 L1CAM FNDC3A CMYA5 KIAA0319

2.11e-032091597IPR003961
PathwayREACTOME_CDC42_GTPASE_CYCLE

STARD8 ARHGEF12 ARHGAP9 PLEKHG1 SH3PXD2A KCTD3 LAMTOR1 DOCK6

5.29e-051551208M41808
PathwayWP_INFLAMMATORY_RESPONSE_PATHWAY

VTN FN1 LAMB1 TNFRSF1A

1.15e-04301204M39641
PathwayWP_INFLAMMATORY_RESPONSE_PATHWAY

VTN FN1 LAMB1 TNFRSF1A

1.15e-04301204MM15812
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

PITPNM2 FN1 MAP1A MYO5A MYO5B MARS1 SPTB L1CAM ARHGEF12 KIAA1549 RPSA SORBS1 PGM1 LRIG1 AP1G1 WASHC5 RPTOR NISCH SLC27A1 TRAPPC10 SLC17A7 MAP7D2 DLG4 EIF3A DNAH6 UTRN CEP170B

5.25e-1014311612737142655
Pubmed

The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.

ACTA2 ETV1 ETV4 ETV5

1.53e-087161418977342
Pubmed

Pbx Regulates Patterning of the Cerebral Cortex in Progenitors and Postmitotic Neurons.

ETV1 ETV4 ETV5 LHX6 PBX2 SMAD2

3.02e-0840161626671461
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

PITPNM2 LRFN1 SZT2 L1CAM NSD1 AMBRA1 CHD8 RPSA PRAG1 TBC1D17 PLEKHG1 RPTOR NISCH MCM3AP PKD1 C19orf44 LRP5 DENND5A DOCK6 CEP170B AHNAK2

4.72e-0811051612135748872
Pubmed

ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

ETV1 ETV4 ETV5

9.74e-083161322425584
Pubmed

PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro.

ETV1 ETV4 ETV5

9.74e-083161312871699
Pubmed

Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.

ETV1 ETV4 ETV5

9.74e-083161325203299
Pubmed

Differential expression patterns of the PEA3 group transcription factors through murine embryonic development.

ETV1 ETV4 ETV5

9.74e-08316139285689
Pubmed

The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.

ETV1 ETV4 ETV5

9.74e-083161321689625
Pubmed

Expression patterns of the Ets transcription factors from the PEA3 group during early stages of mouse development.

ETV1 ETV4 ETV5

9.74e-083161311578874
Pubmed

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.

ETV1 ETV4 ETV5

9.74e-083161328161714
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

SORBS1 CDK14 PRAG1 PPM1H CEP350 CDCA2 PLEKHG1 VPS13D ALMS1 SH3PXD2A STARD9 RPTOR PATJ DOCK6 UTRN CEP170B WDR62 AHNAK2

1.15e-078611611836931259
Pubmed

Expression of dopamine pathway genes in the midbrain is independent of known ETS transcription factor activity.

ETV1 ETV4 ETV5 TH

1.42e-0711161420610757
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

COL17A1 MYO5B KIAA1549 SORBS1 KIAA0319 VPS13D ALMS1 MCM3AP

1.78e-07130161812421765
Pubmed

Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.

CHERP FAT3 SPTB PKD1L1 ETV1 NSD1 CHD8 TACC2 GPATCH8 C2orf68 TXNDC11 GREB1L STXBP3 WASHC5 SH3PXD2A SLC27A1 PKD1 PBX3 ZBTB18 UTRN CEP170B

2.29e-0712151612115146197
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

DDAH2 FN1 MYO5B ARHGEF12 PTPN23 ITGA1 PGM1 FAH VPS13D SLC12A1 MOGS SLC12A9 P3H1 ATP6AP2 PKD1 C5 LAMTOR1 PATJ UTRN

2.77e-0710161611919056867
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

CCDC170 CACNA1F FAT4 FN1 CENPF CANX ARHGAP9 PGM1 MOGS P3H1 MCM3AP PKD1 EEF1AKMT1 EIF3A PBX2 UTRN

3.61e-077361611629676528
Pubmed

β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1.

ETV1 ETV4 ETV5

3.88e-074161326627735
Pubmed

Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin.

FN1 ACTA2 SMAD2

3.88e-074161317706958
Pubmed

Pea3 transcription factor family members Etv4 and Etv5 mediate retrograde signaling and axonal growth of DRG sensory neurons in response to NGF.

ETV1 ETV4 ETV5

3.88e-074161324089499
Pubmed

The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.

ETV1 ETV4 ETV5

3.88e-074161320062082
Pubmed

ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.

ETV1 ETV4 ETV5

3.88e-074161328408625
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MAP1A ARHGEF12 CEP350 VPS13D ALMS1 EIF3A UTRN CEP170B WDR62

6.24e-07209161936779422
Pubmed

An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.

ETV1 ETV4 ETV5

9.67e-075161327783944
Pubmed

Neural crest-specific deletion of Rbfox2 in mice leads to craniofacial abnormalities including cleft palate.

FN1 ACTA2 TH SMAD2

1.00e-0617161431241461
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

KIAA1549 SORBS1 PPM1H PLEKHG1 ALMS1 SH3PXD2A TRAPPC10 PATJ DOCK6 UTRN CEP170B WDR62

1.27e-064461611224255178
Pubmed

Cv2, functioning as a pro-BMP factor via twisted gastrulation, is required for early development of nephron precursors.

FN1 ACTA2 CDH11 SMAD2

1.29e-0618161419914233
Pubmed

Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site.

ETV1 ETV4 ETV5

1.93e-066161315466854
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ZSWIM8 ACTR8 FN1 MYO5A SPTB LAMB1 FBXO11 SORBS1 CMYA5 TXNDC11 CEP350 IFT88 NISCH PKD1 DLG4 PBX2 PBX3 CTSB UTRN SMAD2

2.27e-0612851612035914814
Pubmed

New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.

ACTA2 ETV1 ETV4 ETV5

2.49e-0621161425035421
Pubmed

Transforming growth factor beta-SMAD2 signaling regulates aortic arch innervation and development.

FN1 ACTA2 SMAD2

3.36e-067161315528466
Pubmed

Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

FAT4 FAT3 FAT2

3.36e-067161316059920
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARHGEF12 SORBS1 GPATCH8 KIAA0319 PLEKHG1 UNC5A BAZ2A STARD9 NISCH MCM3AP CEP170B

3.42e-064071611112693553
Pubmed

Genomic analysis of mouse retinal development.

PITPNM2 ZSWIM8 VTN LHX4 NSD1 RPSA TACC2 CRHBP CDCA2 BAZ2A ATP6AP2 PKD1 SLC17A7 DLG4 PBX2 PBX3 CDH11

4.73e-0610061611715226823
Pubmed

Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model.

FN1 ACTA2 ITGA10 SLC12A1 PKD1

4.79e-0653161538653356
Pubmed

COP1 is a tumour suppressor that causes degradation of ETS transcription factors.

ETV1 ETV4 ETV5

5.36e-068161321572435
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

MAP1A MYO5A CANX L1CAM NRG2 SORBS1 SH3PXD2A RPTOR DLG4 CEP170B

5.50e-063471611017114649
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

FN1 ACTA2 KIAA1549 SORBS1 STARD9 RPTOR KCTD3 TRAPPC10 MAP7D2 DLG4 CEP170B

5.76e-064301611132581705
Pubmed

Adamts18 modulates the development of the aortic arch and common carotid artery.

FN1 ACTA2 LAMB1 TH

6.11e-0626161434189436
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

UXS1 MYO5A MARS1 NSD1 ARHGEF12 FBXO11 CHD8 RPSA GPATCH8 KIF20B GREB1L PHC3 AP1G1 BAZ2A ATP6AP2 KCTD3 EIF3A LAMTOR1 PATJ UTRN CEP170B

6.22e-0614971612131527615
Pubmed

Network organization of the human autophagy system.

MAP1A KBTBD6 TBC1D2B AMBRA1 PGM1 SH3PXD2A RPTOR EIF3A UTRN CEP170B WDR62

6.70e-064371611120562859
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

PITPNM2 ZSWIM8 TBC1D2B RPSA C2orf68 TBC1D17 CEP350 RIC8B STXBP3 AP1G1 WASHC5 RPTOR MCM3AP NFKBIB KCTD3 C19orf44 DOCK6

7.12e-0610381611726673895
Pubmed

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.

FN1 ACTA2 LAMB1

8.01e-06916139827803
Pubmed

Remotely Produced and Axon-Derived Netrin-1 Instructs GABAergic Neuron Migration and Dopaminergic Substantia Nigra Development.

L1CAM ITGA1 UNC5A TH

1.10e-0530161432562661
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

LRFN1 MYO5A CENPF CANX NSD1 ARHGEF12 CHD8 SORBS1 PPM1H KIAA0319 RPTOR NISCH DLG4 LAMTOR1 CDH11 CEP170B

1.13e-059631611628671696
Pubmed

Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth.

L1CAM SIM1 TH

1.14e-0510161315649943
Pubmed

Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway.

MARS1 RPTOR LAMTOR1

1.14e-0510161322424946
Pubmed

Laminar patterning in the developing neocortex by temporally coordinated fibroblast growth factor signaling.

ETV1 ETV4 ETV5

1.14e-0510161315470137
Pubmed

Etv1 inactivation reveals proprioceptor subclasses that reflect the level of NT3 expression in muscle targets.

ETV1 ETV4 SLC17A7

1.14e-0510161323522042
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

FAT4 UXS1 CANX L1CAM KIAA1549 LAMB1 ITGA1 TXNDC11 MOGS P3H1 ATP6AP2 EDEM2 LRP5 SGCE EIF3A TNFRSF1A SMAD2 WDR62

1.26e-0512011611835696571
Pubmed

The NXSM recombinant inbred strains of mice: genetic profile for 58 loci including the Mtv proviral loci.

ITGA1 PGM1 TH C5

1.26e-053116142165966
Pubmed

Alx4 relays sequential FGF signaling to induce lacrimal gland morphogenesis.

ACTA2 ETV1 ETV4 ETV5

1.44e-0532161429028795
Pubmed

Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling.

ETV4 ETV5 RPTOR LRP5

1.44e-0532161434193412
Pubmed

Emx2 patterns the neocortex by regulating FGF positional signaling.

ETV1 ETV4 ETV5

1.56e-0511161312872126
Pubmed

Coordination of epithelial branching and salivary gland lumen formation by Wnt and FGF signals.

ETV1 ETV4 ETV5

1.56e-0511161321806977
Pubmed

Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.

ETV1 ETV4 ETV5

1.56e-0511161328827401
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

IL12RB2 ZSWIM8 ACTR8 MAP1A TCP11L1 FAT3 KIAA1549 LAMB1 AMBRA1 CHD8 ALMS1 BAZ2A RPTOR MCM3AP DLG4 CEP170B WDR62

1.81e-0511161611731753913
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

ZSWIM8 MAP1A CANX TBC1D2B TACC2 SORBS1 KIF20B ALMS1 RPTOR MCM3AP PATJ CEP170B

2.07e-055881611238580884
Pubmed

Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1.

IFT88 PKD1

2.13e-052161218285569
Pubmed

Pathomechanistic characterization of two exonic L1CAM variants located in trans in an obligate carrier of X-linked hydrocephalus.

CANX L1CAM

2.13e-052161222222883
Pubmed

Opposing effects of collagen I and vitronectin on fibronectin fibril structure and function.

VTN FN1

2.13e-052161224509439
Pubmed

Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains.

ITGA10 ITGA1

2.13e-052161211572855
Pubmed

Ovarian cancer ascites-derived vitronectin and fibronectin: combined purification, molecular features and effects on cell response.

VTN FN1

2.13e-052161223811340
Pubmed

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.

ETV1 ETV4

2.13e-052161225595908
Pubmed

Core-shell PLGA/collagen nanofibers loaded with recombinant FN/CDHs as bone tissue engineering scaffolds.

FN1 CDH11

2.13e-052161224844413
Pubmed

Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.

ETV4 ETV5

2.13e-052161218827017
Pubmed

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease.

IFT88 PKD1

2.13e-052161225999403
Pubmed

A novel dystrophin/utrophin-associated protein is an enzymatically inactive member of the phosphoglucomutase superfamily.

PGM1 PGM5

2.13e-05216128631316
Pubmed

Clinical significance of serum fibronectin and vitronectin levels in melanoma patients.

VTN FN1

2.13e-052161224999757
Pubmed

Interactions between adaptor protein-1 of the clathrin coat and microtubules via type 1a microtubule-associated proteins.

MAP1A AP1G1

2.13e-052161211418592
Pubmed

Myo5b Transports Fibronectin-Containing Vesicles and Facilitates FN1 Secretion from Human Pleural Mesothelial Cells.

FN1 MYO5B

2.13e-052161235563212
Pubmed

Pea3 Transcription Factors, Etv4 and Etv5, Are Required for Proper Hippocampal Dendrite Development and Plasticity.

ETV4 ETV5

2.13e-052161227909004
Pubmed

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature.

VTN FN1

2.13e-052161215687502
Pubmed

Laminin-1 induces endocytosis of 67KDa laminin receptor and protects Neuroscreen-1 cells against death induced by serum withdrawal.

LAMB1 RPSA

2.13e-052161229108990
Pubmed

Vitronectin alters fibronectin organization at the cell-material interface.

VTN FN1

2.13e-052161223899674
Pubmed

Localization of utrophin and aciculin at sites of cell-matrix and cell-cell adhesion in cultured cells.

PGM5 UTRN

2.13e-05216127589238
Pubmed

ETS-related transcription factors ETV4 and ETV5 are involved in proliferation and induction of differentiation-associated genes in embryonic stem (ES) cells.

ETV4 ETV5

2.13e-052161226224636
Pubmed

Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.

PKD1 PAPPA

2.13e-052161231990681
Pubmed

Functional proteomics mapping of a human signaling pathway.

FN1 CANX ARHGAP9 CBLB AP1G1 MCM3AP PKD1 LRP5 PAPPA ASB2 UTRN SMAD2

2.18e-055911611215231748
Pubmed

Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.

L1CAM ETV1 ETV5 TH PTPRN LRP5 PBX2 PBX3

2.39e-05251161829031500
Pubmed

Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders.

AMBRA1 SLC17A7 DLG4

2.69e-0513161329488136
Pubmed

Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome.

ACTA2 ETV4 ETV5

2.69e-0513161320122914
Pubmed

Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon.

TH PBX2 PBX3

2.69e-0513161316438966
Pubmed

Getting in and out from calnexin/calreticulin cycles.

CANX MOGS EDEM2

2.69e-0513161318303019
Pubmed

Role of Fgf8 signalling in the specification of rostral Cajal-Retzius cells.

ETV1 ETV4 ETV5

2.69e-0513161320040495
Pubmed

Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

SPTB ARHGEF12 RPSA ALMS1 PKD1 EIF3A DNAH6

2.82e-05187161726460568
Pubmed

Expansion of the renal capsular stroma, ureteric bud branching defects and cryptorchidism in mice with Wilms tumor 1 gene deletion in the stromal compartment of the developing kidney.

FAT4 ETV4 ETV5 SLC12A1

2.89e-0538161432715478
Pubmed

Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development.

ETV1 ETV4 ETV5

3.41e-0514161320215346
Pubmed

Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

ETV1 ETV4 ETV5

3.41e-0514161314635793
Pubmed

Human transcription factor protein interaction networks.

ACTR8 LHX4 KBTBD6 MYO5A MARS1 CANX ETV4 ETV5 CHD8 RPSA GPATCH8 LHX6 CDCA2 PHC3 HOXB9 ALMS1 NFKBIB EIF3A PBX2

3.70e-0514291611935140242
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PITPNM2 SZT2 TBC1D2B KIAA1549 AMBRA1 FNDC3A CHD8 CDK14 WASHC5 RPTOR DOCK6

3.90e-055291611114621295
Pubmed

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

DDAH2 FAT4 VTN FN1 MYO5A CANX ACTA2 PGM1 FAH RNASE1 SLC12A1 ATP6AP2 C5 PATJ CTSB CDH11

4.02e-0510701611623533145
Pubmed

Patterning and folding of intestinal villi by active mesenchymal dewetting.

FN1 ACTA2 CDH11

4.25e-0515161338781967
Pubmed

E3 ubiquitin ligase SIAH1 mediates ubiquitination and degradation of TRB3.

FN1 RPSA MCM3AP

4.25e-0515161318276110
Pubmed

α5 and αv integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo.

FN1 ACTA2 SMAD2

4.25e-0515161325670798
Pubmed

Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos.

ACTA2 LAMB1 ITGA1

4.25e-0515161310706142
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

STARD8 FN1 MARS1 NSD1 PTPN23 FBXO11 TACC2 GPATCH8 PGM1 PHC3 AP1G1 TRAPPC10 PATJ UTRN SMAD2 UMAD1

4.69e-0510841611611544199
Pubmed

Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.

CCDC170 FER1L6 KCNQ4 LRP5

5.20e-0544161420200978
Pubmed

Identification of Greb1l as a genetic determinant of crisscross heart in mice showing torsion of the heart tube by shortage of progenitor cells.

FN1 ACTA2 GREB1L

5.22e-0516161337852253
Pubmed

Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain.

ETV1 ETV4 ETV5

5.22e-0516161330322923
InteractionGRIN3B interactions

CANX TXNDC11 EDEM2 C19orf44 DLG4

4.26e-06311605int:GRIN3B
InteractionKCTD13 interactions

PITPNM2 FN1 MAP1A MYO5A MYO5B MARS1 SPTB L1CAM ARHGEF12 KIAA1549 RPSA SORBS1 PGM1 LRIG1 AP1G1 WASHC5 RPTOR NISCH SLC27A1 TRAPPC10 SLC17A7 MAP7D2 DLG4 EIF3A DNAH6 UTRN CEP170B

1.39e-05139416027int:KCTD13
InteractionVASP interactions

FN1 MAP1A TBC1D2B ARHGEF12 PTPN23 SORBS1 CEP350 ALMS1 PATJ CEP170B WDR62

2.39e-0529416011int:VASP
InteractionPEX19 interactions

UXS1 MYO5A MYO5B PEX12 PTPRN SLC27A1 DLG4 BTNL9 SMAD2

2.76e-051961609int:PEX19
InteractionRAC1 interactions

FN1 MYO5B CANX TBC1D2B KIAA1549 FTSJ1 ARHGAP9 ITGA1 AKIP1 PLEKHG1 STXBP3 MOGS ATP6AP2 NISCH MCM3AP LRP5 DLG4 SGCE LAMTOR1 TNFRSF1A DOCK6 UTRN

3.60e-05106316022int:RAC1
InteractionNCR3 interactions

THSD4 UXS1 CANX TXNDC11 P3H1 EDEM2 LRP5

4.89e-051201607int:NCR3
InteractionRAB11FIP2 interactions

LRFN1 MYO5B PPM1H SH3PXD2A ATP6AP2 KCTD3

5.20e-05831606int:RAB11FIP2
InteractionOSBPL6 interactions

LRFN1 ARHGEF12 PPM1H ALMS1 SH3PXD2A KCTD3

5.56e-05841606int:OSBPL6
InteractionCAMSAP2 interactions

LRFN1 PPM1H CEP350 SH3PXD2A KCTD3 MAP7D2 CEP170B WDR62

6.27e-051691608int:CAMSAP2
InteractionOS9 interactions

MYO5A CANX LAMB1 TXNDC11 PTPRN EDEM2 FUT9 CTSB SMAD2

6.54e-052191609int:OS9
GeneFamilyMyosins, class V

MYO5A MYO5B

1.04e-04310721100
GeneFamilyCadherin related

FAT4 FAT3 FAT2

1.29e-0417107324
GeneFamilyFibronectin type III domain containing

IL12RB2 LRFN1 FN1 L1CAM FNDC3A CMYA5

3.78e-041601076555
GeneFamilyETS transcription factor family

ETV1 ETV4 ETV5

5.93e-04281073534
GeneFamilyLIM class homeoboxes

LHX4 LHX6

2.20e-03121072522
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

LRFN1 L1CAM NRG2 UNC5A LRIG1

2.70e-031611075593
GeneFamilyStAR related lipid transfer domain containing

STARD8 STARD9

3.46e-03151072759
CoexpressionGSE11386_NAIVE_VS_MEMORY_BCELL_DN

NSD1 CMYA5 CBLB IFIH1 RIC8B NISCH PATJ UTRN

6.00e-061581608M372
CoexpressionAtlaskidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000

THSD4 SGMS2 MYO5B CENPF FAT3 L1CAM CENPU ARHGEF12 ETV4 ETV5 LAMB1 ITGA1 SIM1 CDK14 PPM1H HOXB9 ALMS1 DLG4 CDH11 UMAD1

1.56e-0678315820gudmap_kidney_P4_CapMesRenVes_Crym_1000
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

THSD4 PITPNM2 FAT4 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 STARD9 DOCK6 BTNL9

1.09e-10190161110e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCellChildren_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor

THSD4 PITPNM2 FAT4 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 STARD9 BTNL9

2.09e-0919116110f229abf69a1217194f74b0502486907e07dba989
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

THSD4 FN1 FAT3 ACTA2 SORBS1 ITGA1 PGM5 ASB2 CDH11

2.03e-081801619d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NSD1 SYBU ITGA1 PGM5 CEP350 DOCK6 BTNL9 UTRN CDH11

2.70e-0818616190ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellControl-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class

PITPNM2 FAT4 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

3.39e-081911619c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCellIPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class

PITPNM2 FAT4 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

3.71e-081931619d7750a7575ef257963b7f1c64fa67c52dbff797b
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD4 FAT4 FN1 ACTA2 LAMB1 SORBS1 ITGA1 PGM5 AHNAK2

3.71e-081931619146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCellCOVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type

THSD4 PITPNM2 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 STARD9 BTNL9

4.24e-08196161949cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCellParenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PITPNM2 STARD8 ITGA10 SORBS1 ITGA1 PLEKHG1 RNASE1 DOCK6 BTNL9

4.83e-08199161914a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor

PITPNM2 UXS1 ARHGEF12 CDK14 PLEKHG1 LRIG1 SGCE PATJ

2.02e-071701618269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FAT4 ACTA2 ITGA10 LAMB1 ITGA1 ACSM5 PAPPA CDH11

2.52e-0717516181799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SPTB HEMGN ARHGEF12 ETV5 TRIM10 RNASE1 PTPRN CEP170B

2.75e-071771618b647667da62a91dbe3890820142626e26aa779d2
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP1A HEMGN CENPU CRHBP TRIM10 CDCA2 LRP5 UPK3BL1

3.26e-0718116189dc0563453e24c9d1d975e2e0e1e272487e19908
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP1A HEMGN CENPU CRHBP TRIM10 CDCA2 LRP5 UPK3BL1

3.26e-071811618c5843b89f3d362e236ff76c3279518a2fdfc1f75
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

THSD4 FAT4 FN1 ACTA2 LAMB1 ITGA1 PBX3 CDH11

3.26e-071811618d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

THSD4 PITPNM2 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

3.26e-071811618c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP1A HEMGN CENPU CRHBP TRIM10 CDCA2 LRP5 UPK3BL1

3.26e-07181161814c2dd946e89ba578711c2d25935b6b3d319b701
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

MAP1A HEMGN CENPU CRHBP TRIM10 CDCA2 LRP5 UPK3BL1

3.26e-071811618fcefb5902416c004631f4f8dd5c8f99fe3bd90bc
ToppCell(2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class

SGMS2 FN1 ITGA10 MATN4 SH3PXD2A P3H1 PKD1 CEP170B

3.70e-071841618684d05340a3dfb8aa08b881516a37f9627a10448
ToppCellControl-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class

PITPNM2 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

3.85e-071851618a28187c2fd23564314b35759479ff2ca21f61485
ToppCellControl-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class

PITPNM2 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

4.18e-07187161854d7588172ac145ff5045ad9771636729ca3f0ca
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor

PITPNM2 ITGA10 KIAA1549 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

4.36e-07188161802a62888e9db29d20133eeca1686d302545a39c9
ToppCellFibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4)

FN1 CENPF ACTA2 CENPU KIF20B CDCA2 HOXB9 CDH11

4.36e-071881618be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

THSD4 PITPNM2 ACTA2 ITGA10 NRG2 TACC2 LRIG1 ASB2

4.72e-071901618938d1f66094b1c94606e0d40213a39e5112f3322
ToppCellControl-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class

FAT4 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

4.91e-071911618322237793a1278bafb14e63cab688b353e352dcc
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FN1 ACTA2 SORBS1 ITGA1 CBLB SH3PXD2A STARD9 UTRN

4.91e-07191161804c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

THSD4 FAT4 FAT3 ACTA2 PRAG1 PGM5 PLEKHG1 PBX3

5.11e-07192161872881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD4 PITPNM2 ARHGEF12 SORBS1 SYBU ITGA1 PLEKHG1 RNASE1

5.31e-071931618a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellIPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class

PITPNM2 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

5.53e-071941618169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

FAT3 ETV1 ETV4 ETV5 RPSA ITGA1 PRAG1 CDH11

5.53e-071941618fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c
ToppCellmoderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CENPF CENPU KIF20B CEP350 RNASE1 ALMS1 UTRN WDR62

5.53e-071941618dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCellParenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

STARD8 LHX4 MAP1A SPTB HEMGN CENPU TRIM10 PTPRN

5.74e-0719516181bcc0c8b1281396b1433ce5a2ec8681de47ce9ad
ToppCellParenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

STARD8 LHX4 MAP1A SPTB HEMGN CENPU TRIM10 PTPRN

5.74e-071951618027075e9c62b5754a014a9d1393e1b0f5ae42e41
ToppCellfacs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STARD8 ARHGEF12 ITGA1 PLEKHG1 RNASE1 LRP5 BTNL9 UTRN

5.74e-0719516187f9b7f15006610ad591063d90e90367bd6083c7f
ToppCellCOVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type

FN1 CENPF CENPU LAMB1 KIF20B CDCA2 CDH11 WDR62

5.97e-0719616182ce8a787f2731faa913d20342d73041d59468f27
ToppCellCOVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type

THSD4 PITPNM2 ARHGEF12 SORBS1 ITGA1 PLEKHG1 STARD9 BTNL9

5.97e-0719616184ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 FAT4 FN1 SORBS1 ITGA1 CBLB UTRN CDH11

6.20e-0719716189b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CACNA1F MYO5B SH2D3A SLC12A9 MAP7D2 C5 PATJ UTRN

6.20e-071971618b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SGMS2 FN1 FAT3 ITGA10 P3H1 PAPPA CDH11 PNOC

6.45e-0719816186a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PITPNM2 FN1 FAT3 SPTB ACTA2 SORBS1 PGM5 PCSK7

6.45e-0719816181e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCellFetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FN1 FAT3 ACTA2 LAMB1 ITGA1 CDCA2 CDH11

1.32e-06151161732d35906f4b2bd46b173e87f2dec972eb5da87b3
ToppCellAdult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor

COL17A1 KBTBD6 PEX12 SYBU CMYA5 LHX6 FAT2

1.51e-06154161738d346402417960044ae999e61f0092b46f2b591
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 FAT4 FN1 SORBS1 ITGA1 CBLB CDH11

3.65e-0617616179bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 FAT4 FN1 SORBS1 ITGA1 CBLB CDH11

3.65e-0617616173f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 LRFN1 ACTA2 CENPU SORBS1 ITGA1 CDH11

3.79e-061771617b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCDC170 MAP1A CENPF CENPU CEP350 ALMS1 WDR62

4.08e-061791617d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCDC170 MAP1A CENPF CENPU CEP350 ALMS1 WDR62

4.08e-061791617e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

FN1 ITGA10 LAMB1 NBPF6 SYBU ITGA1 DOCK6

4.08e-06179161798c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCell10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue

SGMS2 FN1 ITGA10 ETV5 RNASE1 SLC27A1 CTSB

4.39e-061811617d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa
ToppCell(2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class

SGMS2 FN1 ITGA10 SH3PXD2A P3H1 PKD1 CEP170B

4.39e-06181161756ae86072858c156681507aecd1bc6cb0a3372d2
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor

THSD4 ITGA10 SORBS1 ITGA1 STARD9 DOCK6 BTNL9

4.56e-0618216178b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD4 FAT4 FN1 ACTA2 LAMB1 SORBS1 ITGA1

4.72e-061831617af8d86f15a549064530d94bd47081daf59d58ecd
ToppCellCOVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

THSD4 SPTB TACC2 SORBS1 CMYA5 PGM5 GREB1L

5.07e-061851617549eeb521c3985bff396ea0f202db21822efa51f
ToppCellCOVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

THSD4 ITGA1 PGM5 PLEKHG1 UNC5A CATSPERB DOCK6

5.07e-0618516174a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

THSD4 ETV1 TACC2 SORBS1 CMYA5 GREB1L PATJ

5.07e-0618516176baccb26f999145e51b91d94315bf8d4655bef31
ToppCellCOVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

THSD4 ITGA1 PGM5 PLEKHG1 UNC5A CATSPERB DOCK6

5.07e-06185161736ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CCDC170 MYO5B ETV5 CRHBP PGM5 RNASE1 NISCH

5.26e-0618616179673367cb53bafb873a01ef6bda11d9f392ce648
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ACTA2 TBC1D2B LAMB1 ITGA1 STARD9 DOCK6 UTRN

5.26e-061861617888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FN1 CENPF CENPU KIF20B CDCA2 CDH11 WDR62

5.44e-061871617e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCellFetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

THSD4 ITGA10 SORBS1 ITGA1 PPM1H PLEKHG1 BTNL9

5.44e-06187161797b2463fb37e7196dd2f92553acf8e7bc3ec40dd
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FN1 CENPF CENPU KIF20B CDCA2 CDH11 WDR62

5.44e-061871617cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACTA2 SORBS1 ITGA1 PGM5 FUT9 ASB2 AHNAK2

5.44e-0618716173912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCellAdult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor

THSD4 ITGA10 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

5.64e-061881617e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

THSD4 PITPNM2 ACTA2 NRG2 TACC2 LRIG1 ASB2

5.64e-061881617f54b063025d80de631382bf5326bc40aab7f7d00
ToppCellMesenchymal_cells-Osteoblasts|World / Lineage and Cell class

SGMS2 FAT3 ITGA10 SYBU HOXB9 SH3PXD2A P3H1

5.64e-06188161789f7f5a51be7e046a63e2413f86c521ae4b6718f
ToppCellIPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class

PITPNM2 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 BTNL9

5.84e-061891617ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ACTA2 NRG2 TACC2 PGM5 LRIG1 ASB2 AHNAK2

5.84e-061891617da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCellRA-10._Endothelium_II|RA / Chamber and Cluster_Paper

FN1 ITGA10 ITGA1 PPM1H PLEKHG1 DOCK6 CDH11

5.84e-061891617c81787a8c662db5d7814c583dd64562857629e81
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 LAMB1 AMBRA1 SIM1 SLC12A1 PATJ UTRN

5.84e-061891617830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA2 ETV1 TACC2 SYBU CMYA5 PGM5 ASB2

5.84e-0618916174dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

THSD4 ITGA10 SORBS1 ITGA1 PLEKHG1 KCTD3 BTNL9

5.84e-061891617b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA2 ETV1 TACC2 SYBU CMYA5 PGM5 ASB2

5.84e-0618916170d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FN1 FAT3 ETV1 LAMB1 CBLB PGM5 CDH11

6.04e-0619016171196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCellIPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class

PITPNM2 ITGA10 ARHGEF12 SORBS1 ITGA1 PLEKHG1 BTNL9

6.04e-061901617b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 FN1 FAT3 ACTA2 SORBS1 ITGA1 CDH11

6.04e-06190161770c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCellP07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

VTN CENPF ETV4 LAMB1 ARHGAP9 ITGA1 CDCA2

6.25e-061911617ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 FN1 FAT3 ACTA2 SORBS1 ITGA1 CDH11

6.25e-061911617107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FAT3 ACTA2 SORBS1 ITGA1 LRIG1 ASB2 AHNAK2

6.25e-061911617de2cd94ee88a7754f86d39469e38374d668210c7
ToppCellCOVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

CENPF HEMGN CENPU KIF20B TRIM10 CDCA2 WDR62

6.25e-061911617bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FAT4 LAMB1 ITGA1 LHX6 CRHBP DOCK6 BTNL9

6.25e-061911617dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 FN1 FAT3 ACTA2 SORBS1 ITGA1 CDH11

6.25e-061911617bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCellControl-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

ETV1 ARHGEF12 TACC2 SORBS1 LRIG1 CATSPERB PATJ

6.47e-0619216171bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCellEndothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor

THSD4 PITPNM2 ITGA10 SORBS1 ITGA1 PLEKHG1 BTNL9

6.47e-0619216171e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCellMS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster

ACTA2 ARHGEF12 CDK14 IFIH1 SLC12A9 NFKBIB ZBTB18

6.47e-061921617c6722bf142c84ccedd99c1a3344085aecb4cbab4
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ETV4 ETV5 RPSA ITGA1 PRAG1 FAH CDH11

6.47e-0619216174c9d748f209cc1e13d28c8c7f5180ab8522e0fbf
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CENPF CENPU IDI2 KIF20B CDCA2 GPAT2

6.61e-0612616168ae631694bbba40f64e55e2be8162d7a40eeadc5
ToppCellcontrol-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TBC1D2B ARHGAP9 ITGA1 CBLB PHC3 PCSK7 UTRN

6.69e-06193161789d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC170 THSD4 ACTA2 LAMB1 SORBS1 ITGA1 CDH11

6.69e-061931617c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCellILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

THSD4 FN1 ACTA2 LAMB1 SORBS1 CDH11 AHNAK2

6.69e-061931617084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO5A SPTB L1CAM FAT2 SLC17A7 PATJ ZBTB18

6.69e-0619316175fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PITPNM2 ITGA10 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

6.69e-061931617f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor

PITPNM2 ITGA10 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

6.69e-06193161739c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCellCOVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

THSD4 PITPNM2 SORBS1 ITGA1 PLEKHG1 DOCK6 BTNL9

6.69e-061931617979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CCDC170 THSD4 ACTA2 LAMB1 SORBS1 ITGA1 CDH11

6.69e-0619316175b602b1702283184bd3943c2a6f2290b7c37e407
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 ITGA10 KIAA1549 SORBS1 ITGA1 DOCK6 BTNL9

6.92e-06194161768004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PITPNM2 SGMS2 ETV1 ETV5 TACC2 CATSPERB PATJ

6.92e-06194161797534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PITPNM2 FAT4 ITGA10 KIAA1549 SORBS1 ITGA1 BTNL9

6.92e-06194161740842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CRHBP PLEKHG1 RNASE1 STARD9 DOCK6 BTNL9 UTRN

6.92e-061941617f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FAT4 FN1 ACTA2 ITGA10 LAMB1 ITGA1 PAPPA

6.92e-0619416178fae8061b350336299aa81f378e07deadbd55123
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FAT4 FN1 FAT3 LAMB1 ITGA1 CDK14 CDH11

6.92e-061941617011e14d9ed1393275f892060e7708ffadcd0767f
DrugSF-6,5

VTN FN1 FNDC3A

1.36e-0641603CID000126860
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

FN1 MAP1A ETV5 SORBS1 CDK14 SLC17A7 SGCE ZBTB18 AHNAK2

4.88e-0617816096454_UP
Drugethylene acrylic acid

VTN FN1 FNDC3A

6.71e-0661603CID000062701
DrugPiroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A

FN1 CANX TBC1D2B ETV5 PEX12 VPS13D MCM3AP PBX3 CTSB

9.79e-0619416091405_DN
DrugParomomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A

ZNF174 TCP11L1 ETV5 LAMB1 FBXO11 LHX6 IFIH1 NFKBIB UTRN

1.06e-0519616094420_DN
DrugVancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A

COL17A1 TCP11L1 ACTA2 SH2D3A ARHGEF12 SH3PXD2A MCM3AP NFKBIB SLC17A7

1.20e-0519916092498_UP
Drughaloperidol; Up 200; 10uM; MCF7; HG-U133A

TCP11L1 L1CAM ETV5 FBXO11 FNDC3A TBC1D17 PTPRN C5 PNOC

1.20e-051991609492_UP
DrugYIGSR

VTN FN1 LAMB1 FNDC3A RPSA CTSB

2.00e-05791606CID000123977
Drugoxypertine

VTN FN1 ITGA10 FNDC3A ITGA1

2.39e-05491605CID000004640
DrugGrgd Peptide

VTN FN1 FNDC3A

3.94e-05101603CID000126679
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

MAP1A SPTB SORBS1 KIAA0319 SLC17A7 CATSPERB ZBTB18 AHNAK2

5.09e-0518516085935_UP
Drugestradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A

CENPF TCP11L1 ETV5 SYBU LHX6 ALMS1 DOCK6 WDR62

6.61e-0519216085238_UP
DrugForskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A

MARS1 ARHGEF12 NRG2 ETV5 CDK14 C2orf68 IFT88 BAZ2A

6.61e-0519216087104_DN
DrugMesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A

FN1 MARS1 ZNF174 ARHGEF12 AMBRA1 CDK14 LILRB1 UTRN

6.61e-0519216086162_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A

ACTR8 FN1 MAP1A AMBRA1 FTSJ1 FBXO11 SH3PXD2A UTRN

7.11e-0519416081377_DN
DrugRgdv tetrapeptide

VTN FN1 FNDC3A

7.15e-05121603CID003022178
DrugCefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A

ZSWIM8 FN1 LHX6 C2orf68 SLC12A9 LRP5 UTRN WDR62

7.37e-0519516085424_DN
Drugmonastrol; Up 200; 100uM; MCF7; HG-U133A

THSD4 CHERP GPATCH8 CBLB VPS13D RNASE1 PCSK7 WDR62

7.37e-051951608596_UP
DrugPrednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A

MARS1 ZNF174 TCP11L1 ETV5 LAMB1 SYBU CDH11 AHNAK2

7.37e-0519516083542_UP
DrugClorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

MARS1 FBXO11 LHX6 LILRB1 PHC3 LRIG1 PCSK7 DOCK6

7.64e-0519616087025_UP
DrugPirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A

TCP11L1 AMBRA1 FNDC3A VPS13D C5 PATJ DOCK6 WDR62

7.64e-0519616087226_DN
DrugMiconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A

MAP1A ETV5 TACC2 CEP350 TH VPS13D PATJ WDR62

7.64e-0519616086615_DN
DrugCarisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A

MAP1A ARHGEF12 ETV5 AMBRA1 VPS13D SLC12A9 BAZ2A PCSK7

7.64e-0519616086610_DN
DrugDequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A

ACTR8 TBC1D17 IFIH1 TH BAZ2A LRP5 PATJ CEP170B

7.64e-0519616085396_DN
DrugS-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A

ZNF174 TCP11L1 SORBS1 CEP350 PHC3 VPS13D BAZ2A SGCE

7.92e-0519716086471_UP
DrugChloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A

ARHGEF12 LAMB1 FTSJ1 SYBU CBLB IFIH1 NFKBIB PCSK7

7.92e-0519716087012_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

AMBRA1 FTSJ1 VPS13D BAZ2A TRAPPC10 PCSK7 LRP5 C5

7.92e-0519716086222_DN
DrugCefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A

ETV1 ITGA10 NRG2 FNDC3A TBC1D17 IFIH1 ALMS1 DOCK6

7.92e-0519716087148_UP
DrugGibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A

TCP11L1 ETV5 SORBS1 TBC1D17 PHC3 DOCK6 UTRN AHNAK2

7.92e-0519716084818_UP
DrugVigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A

ZSWIM8 ETV5 TBC1D17 ALMS1 P3H1 NFKBIB PATJ WDR62

7.92e-0519716085415_DN
DrugPicotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A

FN1 LHX6 IFIH1 ALMS1 SLC12A9 NFKBIB TRAPPC10 UTRN

7.92e-0519716086787_DN
DrugVincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A

MAP1A ETV1 ETV5 FNDC3A GREB1L PHC3 VPS13D MCM3AP

7.92e-0519716083784_DN
DrugMinoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A

FN1 ACTA2 C2orf68 NFKBIB EDEM2 PATJ UTRN WDR62

7.92e-0519716081496_DN
DrugUngerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A

SZT2 TBC1D2B FBXO11 C2orf68 VPS13D MOGS NFKBIB TRAPPC10

7.92e-0519716082514_DN
Drugclozapine; Down 200; 10uM; MCF7; HT_HG-U133A

TCP11L1 C2orf68 BAZ2A NFKBIB SGCE CDH11 WDR62 AHNAK2

7.92e-0519716085589_DN
Drugnovobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A

CHERP FN1 ETV1 CDK14 PGM1 RNASE1 SLC17A7 C5

7.92e-051971608576_UP
Drugnocodazole; Down 200; 1uM; MCF7; HG-U133A

ARHGEF12 FBXO11 TACC2 VPS13D RIC8B BAZ2A NFKBIB EIF3A

8.20e-051981608621_DN
DrugDoxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A

TCP11L1 TBC1D2B SORBS1 LHX6 BAZ2A PATJ UTRN AHNAK2

8.20e-0519816083479_UP
DrugDiperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A

FN1 SPTB ETV1 ETV5 SLC12A9 BAZ2A NFKBIB PCSK7

8.20e-0519816084498_DN
DrugSulfasalazine [599-79-1]; Up 200; 10uM; PC3; HT_HG-U133A

ZNF174 TCP11L1 ETV5 TBC1D17 IFIH1 PHC3 BAZ2A WDR62

8.20e-0519816086346_UP
Drug(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; PC3; HT_HG-U133A

ETV1 ARHGEF12 FBXO11 FNDC3A SORBS1 ITGA1 VPS13D UTRN

8.20e-0519816084259_DN
DrugSulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A

ZNF174 FNDC3A VPS13D LRIG1 NFKBIB DOCK6 UTRN WDR62

8.20e-0519816084733_DN
Drugrosiglitazone maleate; Up 200; 10uM; HL60; HG-U133A

ACTA2 NSD1 ARHGEF12 ETV5 FNDC3A VPS13D SLC17A7 PAPPA

8.20e-051981608369_UP
Drug1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A

STARD8 TCP11L1 AMBRA1 FNDC3A GPATCH8 AKIP1 LHX6 PCSK7

8.20e-0519816082_UP
DrugCefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A

CENPF MARS1 ETV5 FBXO11 VPS13D C5 UTRN CEP170B

8.49e-0519916085787_DN
DrugMoroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A

ZSWIM8 FN1 ETV5 C2orf68 ALMS1 AP1G1 BAZ2A PCSK7

8.80e-0520016082027_DN
Diseaseretinal vasculature measurement

CCDC170 MYO5A ARHGAP9 ITGA1 PRAG1 COG8 CDCA2 PLEKHG1 SLC12A9 SH3PXD2A EDEM2 PATJ SMAD2

4.03e-0651715613EFO_0010554
Diseasebipolar disorder (implicated_via_orthology)

ETV1 ETV4 ETV5

5.00e-0671563DOID:3312 (implicated_via_orthology)
Diseaseautosomal dominant polycystic kidney disease (implicated_via_orthology)

IFT88 PKD1 LRP5

5.06e-05141563DOID:898 (implicated_via_orthology)
Diseaseautosomal dominant polycystic kidney disease (is_implicated_in)

PKD1 LRP5

1.65e-0441562DOID:898 (is_implicated_in)
Diseasecoronary artery disease

FAT4 FN1 HEMGN ETV1 ARHGEF12 ITGA1 KIAA0319 IFIH1 PLEKHG1 RNASE1 RPTOR EDEM2 C5 DENND5A PBX2 DOCK6 SMAD2

2.05e-04119415617EFO_0001645
Diseaseenergy expenditure

PPM1H PATJ UMAD1

3.86e-04271563EFO_0005109
Diseasenischarin measurement

VTN NISCH

4.11e-0461562EFO_0801841
DiseaseMental Depression

ANKK1 CRHBP TH DLG4 SGCE TNFRSF1A PNOC

4.23e-042541567C0011570
DiseaseDevelopmental Academic Disorder

TH SLC17A7 PNOC

4.79e-04291563C1330966
DiseaseLearning Disorders

TH SLC17A7 PNOC

4.79e-04291563C0023186
DiseaseLearning Disturbance

TH SLC17A7 PNOC

4.79e-04291563C0751263
DiseaseAdult Learning Disorders

TH SLC17A7 PNOC

4.79e-04291563C0751262
DiseaseLearning Disabilities

TH SLC17A7 PNOC

4.79e-04291563C0751265
Diseaseneuroimaging measurement

THSD4 SZT2 FAT3 ARHGEF12 RPSA TACC2 KIF20B PGM1 PLEKHG1 SH3PXD2A SLC27A1 PKD1 PAPPA PBX3 CDH11

5.70e-04106915615EFO_0004346
Diseasepolycystic liver disease (implicated_via_orthology)

PKD1 LRP5

5.73e-0471562DOID:0050770 (implicated_via_orthology)
Diseasechitinase-3-like protein 2 measurement

VTN RPSA

7.62e-0481562EFO_0801471
DiseaseEwings sarcoma

ETV1 ETV4

7.62e-0481562C0553580
Diseasecortical surface area measurement

THSD4 PITPNM2 DDAH2 FAT3 ARHGEF12 RPSA SYBU AKIP1 KIF20B PGM1 PLEKHG1 LRIG1 EDEM2 PKD1 PAPPA ZBTB18 CDH11

7.92e-04134515617EFO_0010736
Diseasecortical thickness

THSD4 PITPNM2 FAT3 ARHGEF12 RPSA TACC2 SYBU KIF20B PGM1 PLEKHG1 VPS13D SH3PXD2A KCTD3 PKD1 CDH11

8.59e-04111315615EFO_0004840
DiseaseDepressive disorder

ANKK1 CRHBP TH DLG4 SGCE TNFRSF1A PNOC

9.05e-042891567C0011581
Diseaseobesity (implicated_via_orthology)

FAT4 ETV1 ETV4 ETV5 SIM1 ALMS1

1.02e-032151566DOID:9970 (implicated_via_orthology)
DiseaseCongenital disorder of glycosylation

PGM1 COG8 MOGS

1.07e-03381563cv:C0282577
Diseasetranscription factor IIIb 90 kda subunit measurement

VTN RPSA

1.22e-03101562EFO_0020778
Diseasethoracic aortic aneurysm (is_implicated_in)

THSD4 ACTA2

1.48e-03111562DOID:14004 (is_implicated_in)
DiseaseCopper-Overload Cirrhosis

ACTA2 SMAD2

1.48e-03111562C1876165
Diseasemyocardial infarction (biomarker_via_orthology)

FN1 SLC27A1 TNFRSF1A CTSB SMAD2

1.65e-031601565DOID:5844 (biomarker_via_orthology)
DiseaseProstatic Neoplasms

CENPF ETV1 ETV4 ETV5 MATN4 HOXB9 BAZ2A EIF3A PATJ CTSB

1.69e-0361615610C0033578
DiseaseMalignant neoplasm of prostate

CENPF ETV1 ETV4 ETV5 MATN4 HOXB9 BAZ2A EIF3A PATJ CTSB

1.69e-0361615610C0376358
DiseaseTobacco Dependence

PLEKHG1 RPTOR

2.42e-03141562C0040332
DiseaseNicotine Dependence

PLEKHG1 RPTOR

2.42e-03141562C0028043
DiseaseNicotine Use Disorder

PLEKHG1 RPTOR

2.42e-03141562C0376384
DiseaseSchizophrenia

ANKK1 CACNA1F MYO5B AMBRA1 CMYA5 LHX6 LILRB1 SH3PXD2A EDEM2 SLC17A7 DLG4 TNFRSF1A

2.64e-0388315612C0036341
Diseasedepressive disorder (biomarker_via_orthology)

L1CAM CRHBP TH

2.65e-03521563DOID:1596 (biomarker_via_orthology)
DiseaseFamilial thoracic aortic aneurysm and aortic dissection

ACTA2 PKD1 SMAD2

2.80e-03531563C4707243
Diseaseapolipoprotein B measurement

VTN FN1 ITGA1 SIM1 STXBP3 AP1G1 NISCH PCSK7 DLG4 DOCK6

2.87e-0366315610EFO_0004615
Diseasefocal segmental glomerulosclerosis

ALMS1 DNAH6

3.17e-03161562EFO_0004236
Diseaseautosomal recessive polycystic kidney disease (implicated_via_orthology)

IFT88 PKD1

3.17e-03161562DOID:0110861 (implicated_via_orthology)
Diseaseglomerulonephritis (is_marker_for)

FN1 TNFRSF1A

4.48e-03191562DOID:2921 (is_marker_for)
Diseasecolorectal cancer, inflammatory bowel disease

ALMS1 KCNQ4

4.48e-03191562EFO_0003767, MONDO_0005575
Diseasewhite matter microstructure measurement

CHERP RPSA PLEKHG1 SH3PXD2A CATSPERB ASB2 PBX3

4.84e-033901567EFO_0005674
Diseasejuvenile dermatomyositis

SYBU GPAT2

4.96e-03201562EFO_0000557
DiseaseIgA glomerulonephritis (is_marker_for)

FN1 TNFRSF1A

4.96e-03201562DOID:2986 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
DVAAPEHISYVPQLS

UPK3BL1

36

B0FP48
DLPDHLLSYDGSENL

UMAD1

106

C9J7I0
IEVDQIYHLASPASP

UXS1

151

Q8NBZ7
TYDATILDANLPSHV

COL17A1

206

Q9UMD9
YAVDVTLDPASAHPS

BTNL9

326

Q6UXG8
ESTAPAPESITLHDY

CHD8

81

Q9HCK8
PSFHPLSDELVNYVN

CTSB

21

P07858
GIAIPLTDNFYHADP

CATSPERB

876

Q9H7T0
NIDAYIATHPTAFPA

ASB2

466

Q96Q27
PEDPHDEHYLLATQS

ACTR8

416

Q9H981
PSPDSTREDLAYCEH

BAZ2A

1541

Q9UIF9
LPPDAASSDVNYLIE

ANKK1

56

Q8NFD2
TDADIGPNSELHYSL

FAT4

2491

Q6V0I7
YQISEHAPEASQPAE

AKIP1

151

Q9NQ31
SFYNELRVAPEEHPT

ACTA2

91

P62736
SILYPQDLADSHLPE

ALMS1

771

Q8TCU4
FDPPLHSTAIYADEE

CENPU

71

Q71F23
TPAYSSHDPEALTRE

ACSM5

521

Q6NUN0
QAALSHEYFSDLPPR

CDK14

411

O94921
PDEGILAVYSLAPHN

AMBRA1

916

Q9C0C7
SEALPEHTPYCEASN

CEP170B

131

Q9Y4F5
DVSAHPRNPDYEESG

C2orf68

76

Q2NKX9
DYQIAIPDSHLPVSE

ARHGEF12

1231

Q9NZN5
EDTVPLSHLDESPAY

ETV4

451

P43268
LSHLDESPAYLPELA

ETV4

456

P43268
PEDSVNEVYLTPSVH

NBPF4

431

Q96M43
HPDPNLTYAADLVET

PGM1

261

P36871
SSASSQNHIPIEPDY

NSD1

891

Q96L73
YSEEQPQEAVPHLEA

P3H1

216

Q32P28
ETVDNLDAYSHIPPQ

PTPN23

406

Q9H3S7
APDELSPEQHNLSLY

KIAA1549

61

Q9HCM3
HPDPNLTYATTLLEA

PGM5

266

Q15124
YSPEHDVSGISDPFL

AP1G1

231

O43747
VYIPFPEDDSNTANH

CACNA1F

111

O60840
SHLSNPYPSEEAKEE

PBX3

256

P40426
RSDYINASPIIEHDP

PTPRN

761

Q16849
HLSNPYPSEEAKEEL

PBX2

266

P40425
SSVSYLGVPAHDLPD

DUSP13

86

Q6B8I1
IASEPAELHVSYAPD

MATN4

536

O95460
YPTNIVAAPLAEEEH

MAP1A

811

P78559
ARLYHPDSTELQPAS

LRIG1

1026

Q96JA1
VDHAAPETYPQDIFS

MAP7D2

601

Q96T17
APALPAQDHYEALRE

LRFN1

596

Q9P244
IPADSFIHVEDYNSP

FUT9

281

Q9Y231
YSRSSADQEEPLPHE

MCM3AP

676

O60318
NPDRQPHDLSIDIYS

LRP5

1021

O75197
THDGYLPSNIDDLPS

IL12RB2

796

Q99665
QVPLFDPDITSDYHS

KCNQ4

656

P56696
DDEYKIPSSHPVSLN

CBLB

706

Q13191
HVSEPIADQSNYKPD

C9orf131

656

Q5VYM1
YIFNTEAHPIDPAAL

EDEM2

471

Q9BV94
DTNHTPVALYPDSDL

NFKBIB

171

Q15653
HNYLPDPSDGDTLES

GPATCH8

1241

Q9UKJ3
EHTIQDIAPNYSPEG

PCSK7

191

Q16549
TQLHYEASVPDTIAP

FAT2

1556

Q9NYQ8
VTEQSHYAPSALPLE

FAT2

3521

Q9NYQ8
VPDYQAESLAFHGLP

ETV1

71

P50549
ATAPPYHDSVDSLRD

NRG2

571

O14511
AHLYIASLPDPQEAT

KIF20B

696

Q96Q89
RSILTAIPNDDPYFH

COG8

256

Q96MW5
AAHSFDIVIADPPYL

EEF1AKMT1

131

Q8WVE0
SQDPYHETLNPDSHL

LAMB1

81

P07942
PSHAPLLNGLDYTVD

LHX4

321

Q969G2
ALSDDIHYTPFSSPE

LHX6

296

Q9UPM6
SPAEDHNAPIEKYDI

L1CAM

636

P32004
LPLTHFEDSPAYLLD

ETV5

481

P41161
FDPDSPHRAYLDVNE

PAPPA

486

Q13219
YNLFHPADPSASRLE

PITPNM2

756

Q9BZ72
DDSLPNSVHEYIPFA

ITGA1

791

P56199
YLDPDQHPFSSADVK

GREB1L

41

Q9C091
LPITYPSAEEDLASH

PHC3

856

Q8NDX5
PAILNESHPENDVYS

HEMGN

466

Q9BXL5
QLSPAAPEHVAAALY

PNOC

71

Q13519
APEHVAAALYQPRAS

PNOC

76

Q13519
GLDDYPRASHPSVTE

MOGS

581

Q13724
YVDSIISHESEDAPP

HOXB9

11

P17482
DHSPDLYSLELAGLD

ATP6AP2

206

O75787
FINTPHELPTYGDSE

DNAH6

406

Q9C0G6
SSHPLYNPAELEEKD

IDI2

86

Q9BXS1
DKYISPSDDPHTNLV

IFT88

341

Q13099
LTAVSSVHPQDPYLD

DOCK6

711

Q96HP0
QHPVSLAPLDESNSY

CENPF

1376

P49454
LLAAVEAFYSPPSHD

CHERP

686

Q8IWX8
SQDHPLPSAERYIDF

CRHBP

126

P24387
DLNYATREDAPIGPH

EIF3A

496

Q14152
THDTDTLYDSAPPIE

FBXO11

906

Q86XK2
TYSSPEDGIHELFPA

FN1

1756

P02751
YVDPTPIANHVISAD

C19orf44

561

Q9H6X5
EISDDEIENPHYSPS

FNDC3A

861

Q9Y2H6
LQVHLSPDADAYSPG

C5

571

P01031
QAYLEPESEDLIPSH

CMYA5

1116

Q8N3K9
PTQEETYPSNILSHE

CENPJ

226

Q9HC77
VEDANDHSPYFTNPL

FAT3

1556

Q8TDW7
TYDLVPDAPCDIDHA

GPAT2

331

Q6NUI2
DLPSPSFENAHDEYL

IFIH1

101

Q9BYX4
TPELNLDQFHDKTPY

CANX

171

P27824
DINDNPPEFLHETYH

CDH11

151

P55287
SEEESPVPLYSHLNS

CEP350

1926

Q5VT06
YDVLHAPPADDRDQS

DENND5A

161

Q6IQ26
APPDITTSYSQHLDN

DLG4

256

P78352
AEPNYHSLPSARTDE

LAMTOR1

36

Q6IAA8
LEDEFPPALQNHAAY

ITGA10

416

O75578
YDDDGTHPSLISNLP

CDCA2

351

Q69YH5
LGAASPAPEETYDHL

CCDC170

11

Q8IYT3
VAEDSDFPIHNLPYG

FAH

6

P16930
VLTDHPYASLTLPDD

DDAH2

201

O95865
HDPSNDAITALSVYL

KCTD3

361

Q9Y597
QSFDPDDPGATLRYH

PKD1L1

806

Q8TDX9
PDHDIYLAAQPRTDL

KBTBD6

391

Q86V97
PGQDTDEPRAEHSYL

PKD1

2101

P98161
SSQDPPADHIYVDVE

FER1L6

1126

Q2WGJ9
DPRADHQPLTEASYV

RPSA

126

P08865
TYSEIPQALHPRDAA

SZT2

931

Q5T011
LSVQLSEDPPAYDHA

TCP11L1

116

Q9NUJ3
PQHSALSYSLDPDAS

UTRN

3371

P46939
DVAAPEHISYVPQLS

UPK3BL2

36

E5RIL1
SPHDEDPQAVTYAEV

LILRB1

551

Q8NHL6
PEDSVNEVYLTPSVH

NBPF6

431

Q5VWK0
DEYESAIDHNGPPLS

RIC8B

206

Q9NVN3
LSPHENDYDNSPTAL

SIM1

641

P81133
ESSAAADDNTDPPHY

SLC12A1

31

Q13621
SYESPALHPSISEEE

SLC17A7

256

Q9P2U7
TSSEEHLPQAASYPA

STARD9

871

Q9P2P6
SQAPYDDPRVTLHEL

STARD9

2746

Q9P2P6
EHLENQPSDPTNTYA

SGMS2

11

Q8NHU3
SLREEDEYSIHPPSS

PEX12

136

O00623
IPHESQVYTLDVPDA

STXBP3

141

O00186
SPYVPVHFDASVEDS

RNASE1

141

P07998
EIIPPLHTDNYDSTN

SGCE

396

O43556
HASTYDNLPELYPAE

STARD8

271

Q92502
LHLAADPYPEVSDVA

RPTOR

816

Q8N122
SSEAYEPRDAHDVSP

AHNAK2

281

Q8IVF2
SSPQDSRLYLVFPHD

TBC1D17

176

Q9HA65
ALLADIEAHYQDPSL

WASHC5

986

Q12768
AEPSQAGAYDRLSPH

ZNF174

176

Q15697
PDDPHRYTLAAQDLV

PPM1H

461

Q9ULR3
VADPHSLLDPNAIYQ

SLC27A1

556

Q6PCB7
PVETPYANVDAEVHA

SYBU

556

Q9NX95
IPLAPASSYHSTDAD

PATJ

1396

Q8NI35
PVNHSLDLQPVTYSE

SMAD2

256

Q15796
EDEQFPSIPALVHSY

SH2D3A

81

Q9BRG2
SHYLVLDENEQPDPS

SH3PXD2A

891

Q5TCZ1
DLPIEDVLAAASYLH

ZBTB18

91

Q99592
TLVLGFYDDAPPQDH

SLC12A9

626

Q9BXP2
SESPRHFIPADYLES

SORBS1

711

Q9BX66
PEASIYNTDHLALSP

SORBS1

1011

Q9BX66
EAPAQYPSEHLIQAT

NISCH

1101

Q9Y2I1
EQETSDPAAHALYPG

ARHGAP9

721

Q9BRR9
AAPDTPYLHVDSAAQ

TACC2

1231

O95359
PADLESPTLAASSYH

TACC2

1871

O95359
NQEYTLAHLEPPDSL

SPTB

1186

P11277
PEEDHRTIYLSSPDS

PRAG1

481

Q86YV5
DPSLDPNVYITREHS

UNC5A

191

Q6ZN44
DAPSSVPHIEENRYL

TXNDC11

571

Q6PKC3
LASPDLQALLEHYSE

WDR62

1491

O43379
KPLLDHSYDPDFNQL

FTSJ1

211

Q9UET6
LIHLTPADYDDFVNA

ZSWIM8

1776

A7E2V4
DYEPAHISLDPQTSH

TRIM10

306

Q9UDY6
QLSEDEAPYHQATPD

PLEKHG1

791

Q9ULL1
YSQEPQLHVEPLADS

TRAPPC10

781

P48553
QAAEAPIYQLPLTHD

THSD4

236

Q6ZMP0
HKPQSLDTDDPATLY

TNFRSF1A

346

P19438
PDNVDAALALPAHSY

VTN

251

P04004
TDLIYPHPNASAEKA

TBC1D2B

171

Q9UPU7
LQDPAYLPEELSALH

MARS1

156

P56192
PDLDLDHPGFSDQVY

TH

216

P07101
TSADRSDHYPAADPD

VPS13D

591

Q5THJ4
QDPELHYLNESASTP

KIAA0319

211

Q5VV43
ENDLTALSYLHEPAV

MYO5A

71

Q9Y4I1
ENDLTALSYLHEPAV

MYO5B

71

Q9ULV0